131 related articles for article (PubMed ID: 31713944)
1. Synthesis and evaluation of in vivo anti-hypothermic effect of all stereoisomers of the thyrotropin-releasing hormone mimetic: Rovatirelin Hydrate.
Kobayashi N; Sato N; Sugita K; Takahashi K; Sugawara T; Tada Y; Yoshikawa T
J Pept Sci; 2019 Dec; 25(12):e3228. PubMed ID: 31713944
[TBL] [Abstract][Full Text] [Related]
2. Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{
Kobayashi N; Sato N; Fujimura Y; Kihara T; Sugita K; Takahashi K; Koike K; Sugawara T; Tada Y; Nakai H; Yoshikawa T
ACS Omega; 2018 Oct; 3(10):13647-13666. PubMed ID: 30411045
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of in Vivo Anti-hypothermic Effect of the N- and C-Terminus Modified Thyrotropin-Releasing Hormone Mimetic: [(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-[3-(thiazol-4-yl)-L-alanyl]-L-prolinamide.
Kobayashi N; Sato N; Sugita K; Kihara T; Koike K; Sugawara T; Tada Y; Yoshikawa T
Chem Pharm Bull (Tokyo); 2021; 69(4):314-324. PubMed ID: 33790077
[TBL] [Abstract][Full Text] [Related]
4. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
Ijiro T; Nakamura K; Ogata M; Inada H; Kiguchi S; Maruyama K; Nabekura J; Kobayashi M; Ishibashi H
Eur J Pharmacol; 2015 Aug; 761():413-22. PubMed ID: 26142830
[TBL] [Abstract][Full Text] [Related]
5. Correction to Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{
Kobayashi N; Sato N; Fujimura Y; Kihara T; Sugita K; Takahashi K; Koike K; Sugawara T; Tada Y; Nakai H; Yoshikawa T
ACS Omega; 2019 Apr; 4(4):6977-6978. PubMed ID: 31459810
[TBL] [Abstract][Full Text] [Related]
6. Non-clinical pharmacokinetic profiles of rovatirelin, an orally available thyrotropin-releasing hormone analogue.
Kobayashi K; Abe Y; Harada H; Oota E; Endo T; Takeda H
Xenobiotica; 2019 Jan; 49(1):106-119. PubMed ID: 29300135
[TBL] [Abstract][Full Text] [Related]
7. Stereoisomers of ketoconazole: preparation and biological activity.
Rotstein DM; Kertesz DJ; Walker KA; Swinney DC
J Med Chem; 1992 Jul; 35(15):2818-25. PubMed ID: 1495014
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of all four stereoisomers of 5-formyl-4-hydroxymethyl-1,3-oxazolidin-2-ones from D-glucosamine.
Murakami T
Carbohydr Res; 2013 Jun; 375():47-54. PubMed ID: 23685810
[TBL] [Abstract][Full Text] [Related]
9. Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
Ijiro T; Yaguchi A; Yokoyama A; Abe Y; Kiguchi S
Eur J Pharmacol; 2020 Sep; 882():173271. PubMed ID: 32534077
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective effects of fungicide difenoconazole and its four stereoisomers on gut barrier, microbiota, and glucolipid metabolism in male mice.
Zhang H; Yang G; Bao Z; Jin Y; Wang J; Chen J; Qian M
Sci Total Environ; 2022 Jan; 805():150454. PubMed ID: 34818760
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological activity of 4-amino-5-chloro-2-methoxy-N-[(2S,4S)-1-ethyl-2-hydroxymethyl-4- pyrrolidinyl]benzamide (TKS159) and its optical isomers.
Yanagi T; Kitajima A; Anzai K; Kodama K; Mizoguchi J; Fujiwara H; Sakiyama H; Kamoda O; Kamei C
Chem Pharm Bull (Tokyo); 1999 Nov; 47(11):1650-4. PubMed ID: 10605060
[TBL] [Abstract][Full Text] [Related]
12. Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission.
Ijiro T; Yaguchi A; Yokoyama A; Kiguchi S
Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):950-958. PubMed ID: 35637550
[TBL] [Abstract][Full Text] [Related]
13. 5-(2-Pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: synthesis of all the stereoisomers and alpha4beta2 nicotinic affinity.
Pallavicini M; Bolchi C; Binda M; Cilia A; Clementi F; Ferrara R; Fumagalli L; Gotti C; Moretti M; Pedretti A; Vistoli G; Valoti E
Bioorg Med Chem Lett; 2009 Feb; 19(3):854-9. PubMed ID: 19097783
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid.
Kaufmann D; Yagen B; Minert A; Wlodarczyk B; Finnell RH; Schurig V; Devor M; Bialer M
Neuropharmacology; 2010 Jun; 58(8):1228-36. PubMed ID: 20230843
[TBL] [Abstract][Full Text] [Related]
15. Effect of thyrotropin releasing hormone on U-50,488H-induced pharmacological responses in mice.
Bhargava HN; Thorat SN
Brain Res; 1993 Oct; 625(1):120-4. PubMed ID: 8242390
[TBL] [Abstract][Full Text] [Related]
16. Enantiomers of diastereomeric cis-N-[1-(2-hydroxy-2-phenylethyl)- 3-methyl-4-piperidyl]-N-phenylpropanamides: synthesis, X-ray analysis, and biological activities.
Brine GA; Stark PA; Liu Y; Carroll FI; Singh P; Xu H; Rothman RB
J Med Chem; 1995 Apr; 38(9):1547-57. PubMed ID: 7739013
[TBL] [Abstract][Full Text] [Related]
17. Facile synthetic route to enantiopure unsymmetric cis-2,5-disubstituted pyrrolidines.
Wang PA; Xu ZS; Chen CF; Gao XG; Sun XL; Zhang SY
Chirality; 2007 Jul; 19(7):581-8. PubMed ID: 17508396
[TBL] [Abstract][Full Text] [Related]
18. Optically active antifungal azoles. V. Synthesis and antifungal activity of stereoisomers of 3-azolyl-2-(substituted phenyl)-1-(1H-1,2,4-triazol-1-yl)-2- butanols.
Tasaka A; Tsuchimori N; Kitazaki T; Hiroe K; Hayashi R; Okonogi K; Itoh K
Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):441-9. PubMed ID: 7774027
[TBL] [Abstract][Full Text] [Related]
19. Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials.
Nishizawa M; Onodera O; Hirakawa A; Shimizu Y; Yamada M;
J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):254-262. PubMed ID: 31937586
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective synthesis of (2S,3S,4R,5S)-5-methylpyrrolidine-3,4-diol derivatives that are highly selective alpha-L-fucosidase inhibitors.
Moreno-Vargas AJ; Carmona AT; Mora F; Vogel P; Robina I
Chem Commun (Camb); 2005 Oct; (39):4949-51. PubMed ID: 16205810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
